NCT04645160
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasm, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Cholangiocarcinoma
Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
503 public trials
160 recruiting studies
Cholangiocarcinoma trial results
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more
- Locations
-
- University of California San Diego UCSD - Moores Cancer Center La Jolla, California, United States
- Tampa General Hospital Cancer Institute Tampa, Florida, United States
- Henry Ford Health System Detroit, Michigan, United States
- Gabrail Cancer Center Research Canton, Ohio, United States
NCT05497531
- Conditions
- Adenocarcinoma, Ampullary Cancer, Carcinoma, +18 more
- Locations
-
- Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States
NCT06529718
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +9 more
- Locations
-
- CHU Amiens Picardie Amiens, France
- Institut de cancerologie de l'Ouest - Angers Angers, France
- Institut du Cancer Avignon Provence Avignon, France
- CHU Besançon Besançon, France
NCT05150691
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
- Locations
-
- Helios Clinical Research Cerritos, California, United States
- California Research Institute Los Angeles, California, United States
- Sharp Memorial Hospital San Diego, California, United States
- Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
- Conditions
- Adenocarcinoma, Borderline Resectable, Carcinoma, +9 more
- Locations
-
- Amsterdam University Medical Center Amsterdam, Netherlands
NCT07619313
- Conditions
- Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Carcinoma, +18 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT07043387
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +17 more
- Locations
-
- National Cancer Center Goyang-si, South Korea
- Samsung Medical Center Seoul, South Korea
- Seoul National University Hospital Seoul, South Korea
- Severance hospital Seoul, South Korea
NCT04891289
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- National Heart, Lung, and Blood Institute (NIH) (Data Collection Only) Bethesda, Maryland, United States
- Washington University (Data Collection Only) St Louis, Missouri, United States
- Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth - Limited Protocol Activities Middletown, New Jersey, United States
NCT07260175
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Uniklinik RWTH Aachen Aachen, Germany
- Universitätsklinikum Bonn Bonn, Germany
- Uniklinikum Essen Essen, Germany
- Krankenhaus Nordwest Frankfurt, Germany